By Rédaction Africa Links 24 with Casey Ross and Matthew Herper and Mohana Ravindranath
Published on 2024-01-17 09:30:22
The biggest conference for health care investors was held in San Francisco last week, and as expected, it rained. Recursion, a biotechnology firm utilizing machine learning for drug development, made a splash by unveiling AI-driven drug discovery software in collaboration with tech giant Nvidia amidst the downpour. Employees handed out black umbrellas adorned with the Recursion logo and lined with neon images of cells, adding a unique touch to their publicity efforts. The company also hosted a satellite event featuring Nvidia’s CEO, Jensen Huang, a figure who has gained celebrity status on Wall Street due to his company’s skyrocketing stock and $1 trillion market value, the sixth highest in the world.
The sight of the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for over four decades, filled with Recursion’s umbrellas seemed to symbolize the readiness of AI for its big debut. However, not everyone at the conference was fully receptive to this message.
The collaboration between Recursion and Nvidia, both prominent players in the tech and biotechnology industries, represented a significant moment in the intersection of AI and healthcare. This partnership and the unveiling of AI-driven drug discovery software signaled the growing influence of artificial intelligence in drug development and the healthcare sector as a whole.
As the rain poured down on the conference, Recursion’s bold and attention-grabbing publicity tactics effectively drew attention to the company’s innovative approach to drug development. Despite the skepticism from some attendees, the sight of Recursion’s branded umbrellas dominating the conference square served as a visual representation of the increasing presence and potential of AI in the healthcare industry. The full story is available on STAT+ for further details.
Read the original article on Africa Health News
